FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988161163> ?p ?o ?g. }

• W1988161163 endingPage "140" @default.
• W1988161163 startingPage "129" @default.
• W1988161163 abstract "ObjectiveTo contrast the limited evidence that androgen therapy is an effective treatment for low sexual desire in women with the extensive literature suggesting that androgens promote breast cancer.DesignEvidence from population studies of women is reviewed on the association between endogenous androgen levels and sexual function or satisfaction. Recent randomized trials of testosterone therapy for low desire are critiqued in terms of methodology and generalizability. Research on endogenous testosterone levels and breast cancer risk in both premenopausal and postmenopausal women is summarized, as are recent studies of androgenic hormonal therapy and breast cancer risk.SettingLiterature review.Patient(s)Not applicable.Intervention(s)Not applicable.Main Outcome Measure(s)Not applicable.Result(s)Endogenous androgen levels are not correlated with sexual desire in population-based studies of aging women. Factors that are strongly associated with low desire include pain with sexual activity, emotional distress, life stress, and relationship conflict. The efficacy of testosterone therapy for women's desire problems is modest. Expectancy effects were not adequately controlled in randomized trials. Epidemiological findings agree that higher endogenous serum androgen levels confer increased breast cancer risk both before and after menopause. Androgenic hormonal replacement regimens also increase the risk of breast cancer.Conclusion(s)Testosterone supplementation should not be prescribed to women with low sexual desire unless long-term studies can demonstrate its efficacy and safety. Treatments for low sexual desire in women should address its common correlates: relationship distress, emotional distress, and dyspareunia. To contrast the limited evidence that androgen therapy is an effective treatment for low sexual desire in women with the extensive literature suggesting that androgens promote breast cancer. Evidence from population studies of women is reviewed on the association between endogenous androgen levels and sexual function or satisfaction. Recent randomized trials of testosterone therapy for low desire are critiqued in terms of methodology and generalizability. Research on endogenous testosterone levels and breast cancer risk in both premenopausal and postmenopausal women is summarized, as are recent studies of androgenic hormonal therapy and breast cancer risk. Literature review. Not applicable. Not applicable. Not applicable. Endogenous androgen levels are not correlated with sexual desire in population-based studies of aging women. Factors that are strongly associated with low desire include pain with sexual activity, emotional distress, life stress, and relationship conflict. The efficacy of testosterone therapy for women's desire problems is modest. Expectancy effects were not adequately controlled in randomized trials. Epidemiological findings agree that higher endogenous serum androgen levels confer increased breast cancer risk both before and after menopause. Androgenic hormonal replacement regimens also increase the risk of breast cancer. Testosterone supplementation should not be prescribed to women with low sexual desire unless long-term studies can demonstrate its efficacy and safety. Treatments for low sexual desire in women should address its common correlates: relationship distress, emotional distress, and dyspareunia." @default.
• W1988161163 created "2016-06-24" @default.
• W1988161163 creator A5000677955 @default.
• W1988161163 date "2008-07-01" @default.
• W1988161163 modified "2023-10-18" @default.
• W1988161163 title "Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?" @default.
• W1988161163 cites W1511930757 @default.
• W1988161163 cites W1962096292 @default.
• W1988161163 cites W1967607481 @default.
• W1988161163 cites W1971293194 @default.
• W1988161163 cites W1975542348 @default.
• W1988161163 cites W1975981979 @default.
• W1988161163 cites W1982153095 @default.
• W1988161163 cites W1983031391 @default.
• W1988161163 cites W1983579825 @default.
• W1988161163 cites W1996799062 @default.
• W1988161163 cites W1998704408 @default.
• W1988161163 cites W2000802645 @default.
• W1988161163 cites W2003917758 @default.
• W1988161163 cites W2004329619 @default.
• W1988161163 cites W2004405160 @default.
• W1988161163 cites W2013794295 @default.
• W1988161163 cites W2017864770 @default.
• W1988161163 cites W2019534570 @default.
• W1988161163 cites W2020253996 @default.
• W1988161163 cites W2022342720 @default.
• W1988161163 cites W2035747196 @default.
• W1988161163 cites W2039527118 @default.
• W1988161163 cites W2040049076 @default.
• W1988161163 cites W2046014999 @default.
• W1988161163 cites W2051518060 @default.
• W1988161163 cites W2052189366 @default.
• W1988161163 cites W2053161405 @default.
• W1988161163 cites W2054339472 @default.
• W1988161163 cites W2055505825 @default.
• W1988161163 cites W2056124963 @default.
• W1988161163 cites W2058850167 @default.
• W1988161163 cites W2061560405 @default.
• W1988161163 cites W2061975232 @default.
• W1988161163 cites W2062126815 @default.
• W1988161163 cites W2063457140 @default.
• W1988161163 cites W2064643739 @default.
• W1988161163 cites W2065796923 @default.
• W1988161163 cites W2067814588 @default.
• W1988161163 cites W2068378277 @default.
• W1988161163 cites W2081756342 @default.
• W1988161163 cites W2082382921 @default.
• W1988161163 cites W2085185698 @default.
• W1988161163 cites W2090258783 @default.
• W1988161163 cites W2090340551 @default.
• W1988161163 cites W2096569810 @default.
• W1988161163 cites W2099346933 @default.
• W1988161163 cites W2111270122 @default.
• W1988161163 cites W2112025328 @default.
• W1988161163 cites W2115379774 @default.
• W1988161163 cites W2118649626 @default.
• W1988161163 cites W2123815431 @default.
• W1988161163 cites W2130838084 @default.
• W1988161163 cites W2133148730 @default.
• W1988161163 cites W2135265943 @default.
• W1988161163 cites W2136650535 @default.
• W1988161163 cites W2140313736 @default.
• W1988161163 cites W2142184845 @default.
• W1988161163 cites W2142229996 @default.
• W1988161163 cites W2145229416 @default.
• W1988161163 cites W2148204966 @default.
• W1988161163 cites W2149994587 @default.
• W1988161163 cites W2150137071 @default.
• W1988161163 cites W2151068947 @default.
• W1988161163 cites W2154434149 @default.
• W1988161163 cites W2157586615 @default.
• W1988161163 cites W2159486739 @default.
• W1988161163 cites W2160698316 @default.
• W1988161163 cites W2161057551 @default.
• W1988161163 cites W2162127061 @default.
• W1988161163 cites W2164379979 @default.
• W1988161163 cites W2244999878 @default.
• W1988161163 cites W2288226673 @default.
• W1988161163 cites W2333490567 @default.
• W1988161163 cites W2336273414 @default.
• W1988161163 cites W2799667742 @default.
• W1988161163 cites W4236566427 @default.
• W1988161163 cites W4248686460 @default.
• W1988161163 cites W4381300628 @default.
• W1988161163 doi "https://doi.org/10.1016/j.fertnstert.2007.05.057" @default.
• W1988161163 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18023435" @default.
• W1988161163 hasPublicationYear "2008" @default.
• W1988161163 type Work @default.
• W1988161163 sameAs 1988161163 @default.
• W1988161163 citedByCount "58" @default.
• W1988161163 countsByYear W19881611632012 @default.
• W1988161163 countsByYear W19881611632013 @default.
• W1988161163 countsByYear W19881611632014 @default.
• W1988161163 countsByYear W19881611632015 @default.
• W1988161163 countsByYear W19881611632016 @default.
• W1988161163 countsByYear W19881611632017 @default.
• W1988161163 countsByYear W19881611632019 @default.
• W1988161163 countsByYear W19881611632020 @default.

• next